BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 31487880)

  • 1. The Role of Exosomes in Pancreatic Cancer.
    Lan B; Zeng S; Grützmann R; Pilarsky C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insight into the Role of Exosomes in Pancreatic Cancer.
    Wang CC; Zhao YM; Wang HY; Zhao YP
    Ann Clin Lab Sci; 2019 May; 49(3):385-392. PubMed ID: 31308040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer and associated exosomes.
    Zhao C; Gao F; Weng S; Liu Q
    Cancer Biomark; 2017 Dec; 20(4):357-367. PubMed ID: 29036786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.
    Nuzhat Z; Kinhal V; Sharma S; Rice GE; Joshi V; Salomon C
    Oncotarget; 2017 Mar; 8(10):17279-17291. PubMed ID: 27999198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes.
    Massoumi RL; Hines OJ; Eibl G; King JC
    Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.
    Jin H; Wu Y; Tan X
    Clin Transl Oncol; 2017 Aug; 19(8):921-930. PubMed ID: 28168600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.
    Qiu J; Yang G; Feng M; Zheng S; Cao Z; You L; Zheng L; Zhang T; Zhao Y
    Mol Cancer; 2018 Jan; 17(1):2. PubMed ID: 29304816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal integrins and their influence on pancreatic cancer progression and metastasis.
    Casari I; Howard JA; Robless EE; Falasca M
    Cancer Lett; 2021 Jun; 507():124-134. PubMed ID: 33741423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Application of Exosomal MicroRNAs in the Treatment of Pancreatic Cancer and Its Research Progress.
    Li X; Jiang W; Gan Y; Zhou W
    Pancreas; 2021 Jan; 50(1):12-16. PubMed ID: 33370018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functions and clinical implications of exosomes in pancreatic cancer.
    Qian L; Yu S; Chen Z; Meng Z; Huang S; Wang P
    Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):75-84. PubMed ID: 30419313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of exosome therapy on pancreatic cancer and its progression.
    El-Tanani M; Nsairat H; Matalka II; Aljabali AAA; Mishra V; Mishra Y; Naikoo GA; Chava SR; Charbe NB; Tambuwala MM
    Med Oncol; 2023 Jul; 40(8):225. PubMed ID: 37405480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential diagnostic and therapeutic roles of exosomes in pancreatic cancer.
    Zhao X; Ren Y; Lu Z
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188414. PubMed ID: 32866530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression.
    Ding Y; Cao F; Sun H; Wang Y; Liu S; Wu Y; Cui Q; Mei W; Li F
    Cancer Lett; 2019 Feb; 442():351-361. PubMed ID: 30419348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis.
    Li J; Li Z; Jiang P; Peng M; Zhang X; Chen K; Liu H; Bi H; Liu X; Li X
    J Exp Clin Cancer Res; 2018 Jul; 37(1):177. PubMed ID: 30064461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes: potential for early detection in pancreatic cancer.
    Lu L; Risch HA
    Future Oncol; 2016; 12(8):1081-90. PubMed ID: 26860951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer.
    Lux A; Kahlert C; Grützmann R; Pilarsky C
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes as therapeutic solutions for pancreatic cancer.
    Farran B; Nagaraju GP
    Drug Discov Today; 2020 Dec; 25(12):2245-2256. PubMed ID: 33127355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
    Papadakos SP; Dedes N; Pergaris A; Gazouli M; Theocharis S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of exosomes in the diagnosis and treatment of pancreatic cancer.
    Ariston Gabriel AN; Wang F; Jiao Q; Yvette U; Yang X; Al-Ameri SA; Du L; Wang YS; Wang C
    Mol Cancer; 2020 Aug; 19(1):132. PubMed ID: 32854710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes released from pancreatic cancer cells enhance angiogenic activities via dynamin-dependent endocytosis in endothelial cells in vitro.
    Chiba M; Kubota S; Sato K; Monzen S
    Sci Rep; 2018 Aug; 8(1):11972. PubMed ID: 30097593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.